期刊文献+

多囊卵巢综合征患者血清内脂素相关研究进展 被引量:6

多囊卵巢综合征患者血清内脂素相关研究进展
原文传递
导出
作者 覃远远 狄文
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2010年第7期554-557,共4页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 内脂素 多囊卵巢综合征 胰岛素抵抗 体重指数 性激素 二甲双胍 visfatin PCOS IR BMI sexual hormones mefformin
  • 相关文献

参考文献2

二级参考文献25

  • 1刘芳,王欣,陆俊茜,谢君,陆惠娟,李青,张锋,贾伟平,项坤三.代谢综合征患者血清内脂素、脂联素水平的变化及影响因素[J].复旦学报(医学版),2007,34(2):239-242. 被引量:8
  • 2郁琦.多囊卵巢综合征诊治标准专家共识[J].中国实用妇科与产科杂志,2007,23(6):474-474. 被引量:110
  • 3Battaglia C, Mancini F, Cianciosi A, et al. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome[J]. Obstet Gynecol, 2008,111 (2) :385-395.
  • 4Shanik M H, Xu Y, Skrha J, et al. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? [J]. Diabetes Care, 2008,31(Suppl 2) :S262-268.
  • 5Panidis D, Farmakiotis D, Rousso D, et al. Plasma visfatin levels in normal weight women with polycystic ovary syndrome [J]. Eur J Intern Med, 2008,19(6) :406-412.
  • 6Valle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus [ J ]. Fertil Steril, 2002,77(6) :1095-1105.
  • 7Zahorska- Markiewicz B, Olszanecka - Glinianowicz M, Janowska J, et al. Serum concentration of visfatin in obese women [J]. Metabolism,2007,56(8) :1131-1134.
  • 8Sethi J K, Vidal- Puig A. Visfatin : the missing link between intraabdominal obesity and diabetes ? [ J ]. Trends Mol Med, 2005,11 (8) :344-347.
  • 9Chen M P, Chung F M, Chang D M, et al. Elevated plasma level of visfatin/pre- B cell colony- enhancing factor in patients with Type 2 diabetes mellitus [ J ]. J Clin Endocrinol Metab,2006,91 (1) :295-299.
  • 10Berndt J, Kloting N, Kralishch S, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans [J]. Diabetes ,2005,54(10) :2911-2916.

共引文献100

同被引文献65

  • 1杨正望,尤昭玲,冯光荣.多囊卵巢综合征与肾虚血瘀关系浅探[J].湖南中医药导报,2004,10(12):4-5. 被引量:31
  • 2杨正望,尤昭玲,张晓红,王瑛,曾明.补肾活血法对多囊卵巢综合征患者月经周期及生殖激素影响的研究[J].中国中医药科技,2006,13(1):5-6. 被引量:34
  • 3黄卫娟,刘嘉茵,李丽娜.环境因素与多囊卵巢综合征发病的相关性分析[J].中华妇产科杂志,2007,42(5):302-304. 被引量:46
  • 4Alireza Esteghamati,Azam Alamdari,Ali Zandieh,Seerat Elahi,Omid Khalilzadeh,Manouchehr Nakhjavani,Alipasha Meysamie.Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity[J].Diabetes Research and Clinical Practice.2010(2)
  • 5Ching-Ju Shen,Eing-Mei Tsai,Jau-Nan Lee,Yi-Ling Chen,Chien-Hung Lee,Te-Fu Chan.The concentrations of visfatin in the follicular fluids of women undergoing controlled ovarian stimulation are correlated to the number of oocytes retrieved[J].Fertility and Sterility.2010(6)
  • 6EIKAWA S,NISHIDA M,MIZUKAMI S,et al. Immune-me diated antitumor effect by type 2 diabetes drug, metformin [J]. Proc Natl Acad Sci USA,2015,112(6) :1809 -1814.
  • 7JOHNSON NP. Metformin use in women with polycystic ova- ry syndrome[J]. Ann Transl Med, 2014,2(6) : 56.
  • 8CADEDDU C, NOCCO S, LUCIA C, et al. Effects of met- formin and exercise training,alone or in association, on cardio- pulmonary performance and quality of life in insulin resistance patients[J]. Cardiovasc Diabetol, 2014 ( 13 ) : 93.
  • 9杨艳,乔杰,李美芝.白细胞介素18、白细胞介素1β与多囊卵巢综合征发病的相关性研究[J].中国实用妇科与产科杂志,2008,24(1):38-40. 被引量:16
  • 10Jakubowicz DJ. Effects of metform in on early pregnancy loss in the polycystic ovary syndrome [ J ]. Clin Endocrinol Me- tob, 2002, 89 (2) : 524 - 529.

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部